1. Mexico Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
Farmacias Benavides, S.A.B. de C.V.

Farmacias Benavides, S.A.B. de C.V.

BEVIDESB.MX
Farmacias Benavides, S.A.B. de C.V.MX flagMexican Stock Exchange
25.00
MXN
- -
- -
8.97BMarket Cap
Farmacias Benavides, S.A.B. de C.V.
BEVIDESB.MX
(Mexican Stock Exchange)

Recent

price

25.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
TTM
FRC
24.16
24.57
23.58
24.79
25.98
25.33
28.06
31.19
32.78
33.02
33.79
34.02
33.92
36.06
39.67
42.13
33.56
Revenue per Share
0.2
0.3
0.21
0.51
0.63
0.71
0.25
0.01
-0.26
-1.67
-0.75
-0.33
-0.68
0.17
0.31
0.69
0.01
Basic EPS, GAAP
-0.24
0.85
- -
- -
-0.23
-0.54
0.27
-0.93
-1.35
-3.51
-2.53
0.91
2.02
2.47
2.61
1.61
-1
Free Cash Flow per Basic Share
0.34
0.16
0.33
- -
0.44
0.7
0.32
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
3.03
2.7
2.43
2.94
3.09
3.13
3.06
3.07
2.82
1.15
0.4
0.1
-0.58
-0.41
-0.1
0.59
3.31
Book Value per Share
3.26
3.31
3.04
3.51
3.67
3.66
3.3
3.53
3.09
1.44
0.83
0.46
-0.26
-0.1
0.32
0.91
3.8
Tangible Book Value per Share
412
409
409
409
409
409
409
409
409
409
409
409
409
409
409
409
380
Basic Weighted Avg Shares
9,945
10,046
9,640
10,133
10,622
10,356
11,473
12,752
13,403
13,498
13,814
13,911
13,869
14,743
16,218
17,226
12,752
Sales/Revenue/Turnover
1.8
1.72
0.97
2.91
3.01
3.89
1.25
0.43
-0.17
-3.85
-1.33
1.26
0.81
3.5
4.34
4.97
0.43
Operating Margin (%)
207
236
234
231
223
- -
184
194
185
175
245
523
882
783
1,021
985
194
Depreciation Expense
82
124
87
210
258
290
101
5
-105
-684
-305
-137
-278
70
127
282
5
Net Income, GAAP
25.8
10.69
- -
26.83
24.28
31.86
31.33
90.44
- -
- -
- -
- -
- -
70.26
63.58
35.41
90.44
Effective Tax Rate (%)
0.83
1.24
0.9
2.07
2.43
2.8
0.88
0.04
-0.78
-5.06
-2.21
-0.98
-2.01
0.47
0.78
1.64
0.04
Profit Margin (%)
-499
-299
-300
74
121
27
66
-159
-177
547
163
-1,646
-1,754
-571
-758
-411
-159
Working Capital
62
- -
- -
- -
- -
- -
- -
- -
- -
1,405
1,474
2,220
2,191
2,603
2,623
2,823
- -
LT Debt
1,369
1,373
1,262
1,471
1,531
1,550
1,495
1,516
1,411
726
441
280
-39
19
182
418
1,516
Total Equity
5.87
10.2
- -
15.22
15.74
17.28
6.43
0.35
- -
- -
- -
- -
- -
3.94
7.44
14.55
0.35
Return on Invested Capital (%)
5.88
13.61
- -
20.81
22.21
22.81
7.99
0.49
- -
- -
- -
- -
- -
4.33
8.46
16.3
0.48
Return on Capital (%)
4.16
10.57
8.3
19.11
20.96
22.81
7.99
0.38
-8.69
-84.38
-96.67
-133.8
- -
- -
- -
- -
0.38
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'15
Sep'15
Dec'15
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
409
409
409
Market Capitalization
5,441
5,510
5,073

Working Capital

FRC

•

in mil. unless spec.
Jun'15
Sep'15
Dec'15
Total Current Assets
3,489
3,356
3,469
Cash, Cash Equivalents & STI
521
505
394
Accounts Receivable, Net
214
215
178
Inventories
2,354
2,306
2,454
Total Current Liabilities
3,358
3,240
3,627
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
56.85%
133.06%
130%
Free Cash Flow
-43.89%
-4.93%
-38.12%
Net Income, GAAP
-180.95%
25.36%
121.78%
Sales/Revenue/Turnover
5.3%
4.58%
6.22%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
14,743
2022
- -
- -
- -
- -
16,218
2023
- -
- -
- -
- -
17,226

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
0.17
2022
- -
- -
- -
- -
0.31
2023
- -
- -
- -
- -
0.69

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Atara Biotherapeutics Inc (0HIY.L)
Parnax Lab Limited (PARNAXLAB.BO)
ST Pharm Co.,Ltd. (237690.KQ)
Decipher Labs Ltd. (DECIPHER.BO)
Trulieve Cannabis Corp. (TRLV)
Camurus AB (CAMX.ST)
Business
Farmacias Benavides SAB de CV (BEVIDESB.MX), a leading Mexican drugstore chain founded in 1917 and headquartered in Monterrey, Nuevo Leon, operates as a subsidiary of Walgreens Boots Alliance Inc and primarily retails pharmaceuticals, health and beauty aids, personal care products, baby care items, groceries, non-perishables, dermo-cosmetics, and household goods through a nationwide network of over 1,300 pharmacies concentrated in northern and western Mexico; the company offers prescription and over-the-counter medications, cosmetics, toiletries, laboratory sample services, home delivery, online pharmacy, prescription processing, and photo services under brands including Almus, Benavides Pharmacies, No.7, Boots, Soap & Glory, and Well Beginnings, while targeting individual consumers with additional features like medical offices and distribution centers. It maintains subsidiaries such as Servicios Operacionales Benavides SA de CV and Servicios Logisticos Benavides SA de CV to support its retail operations across the country. Recent initiatives include ongoing expansion of store locations, a partnership funding over 175 reconstructive surgeries and 1,300 prostheses as of August 2024 to enhance community health impact, and integration of digital payment solutions like cash vouchers and QR codes for online purchases in collaboration with providers such as Nuvei.